DUBLIN--(BUSINESS WIRE)--The "Vascular Screening Devices Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
The vascular screening devices market is expected to register a CAGR of 5.9% during the forecast period.
The growing burden of vascular diseases and the rising geriatric population may be the key factors in the vascular screening devices market. Peripheral artery disease is a condition wherein the peripheral vessels are built up with fat and cholesterol deposits.
- Collaborative Care Diagnostics LLC (Biomedix)
- CorVascular Diagnostics, LLC
- D.E. Hokanson Inc.
- enverdis GmbH
- Koven Technology Inc.
- OMRON HEALTHCARE Co. Ltd
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd
- Unetixs Vascular Inc.
Key Market Trends
Portable Segment is Expected to Hold a Major Market Share in the Vascular Screening Devices Market
Portable vascular screening tests are hand-held devices, which are in the screening tests, which have been becoming popular due to the rising burden of cardiovascular disease and other vascular conditions. According to the World Health Organization, in 2017, approximately 17.9 million people died due to cardiovascular diseases, and it had been the leading cause of death globally. For several cardiovascular diseases, vascular screening tests become very important for further analysis and treatment.
Furthermore, according to the assessment study of the International Journal of Cardiology, 2019, it had been observed that the handheld device accurately measured the maximum plaque height and total plaque area in the carotid artery. Hence, early diagnosis and treatment are of utmost importance, which is expected to impact positively on the vascular screening test market.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America expected to hold a major market share in the global vascular screening devices market, due to increased vascular diseases, such as coronary artery disease, renal artery diseases, and carotid artery aneurysm, among others. Coronary artery disease is the most affected heart disease. According to the Center for Disease Control and Prevention, in 2017, around 365,914 people died due to coronary artery disease in the United States. Furthermore, in 2019, around 18.2 million population aged 20 and above had coronary artery disease. Hence, the aforementioned factors are expected to boost up the demand for vascular screening devices in North America.
Key Topics Covered:
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Vascular Diseases
4.2.2 Increasing Aging Population
4.3 Market Restraints
4.3.1 Reimbursement Issues
4.4 Porter's Five Forces Analysis
5 MARKET SEGMENTATION
5.1 By Product Type
5.2 By End User
5.2.2 Diagnostic Centres/Clinics
5.2.3 Other End Users
5.3.1 North America
184.108.40.206 United States
220.127.116.11 United Kingdom
18.104.22.168 Rest of Europe
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
5.3.4 Rest of the World
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/atjw9l